These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 29703264)

  • 21. Temporal dynamics of cerebrospinal fluid anti-aquaporin-4 antibodies in patients with neuromyelitis optica spectrum disorders.
    Dujmovic I; Mader S; Schanda K; Deisenhammer F; Stojsavljevic N; Kostic J; Berger T; Drulovic J; Reindl M
    J Neuroimmunol; 2011 May; 234(1-2):124-30. PubMed ID: 21316112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuromyelitis optica spectrum disorder: Pathogenesis, treatment, and experimental models.
    Wu Y; Zhong L; Geng J
    Mult Scler Relat Disord; 2019 Jan; 27():412-418. PubMed ID: 30530071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid lactate level in aquaporin-4 antibody positive neuromyelitis optica spectrum disorders: a hint on differential diagnosis and possible immunopathogenesis.
    Wang N; Zhang SN; Xing RJ; Liu MQ; Huang CN; Jiang SM; Li T; Yang CS; Yang L; Zhang LJ
    Mult Scler Relat Disord; 2021 Jan; 47():102629. PubMed ID: 33232908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased frequency of IL-6-producing non-classical monocytes in neuromyelitis optica spectrum disorder.
    Kong BS; Kim Y; Kim GY; Hyun JW; Kim SH; Jeong A; Kim HJ
    J Neuroinflammation; 2017 Sep; 14(1):191. PubMed ID: 28946890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased cerebrospinal fluid progranulin correlates with interleukin-6 in the acute phase of neuromyelitis optica spectrum disorder.
    Kimura A; Takemura M; Saito K; Serrero G; Yoshikura N; Hayashi Y; Inuzuka T
    J Neuroimmunol; 2017 Apr; 305():175-181. PubMed ID: 28100408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-AQP4 autoantibodies promote ATP release from astrocytes and induce mechanical pain in rats.
    Ishikura T; Kinoshita M; Shimizu M; Yasumizu Y; Motooka D; Okuzaki D; Yamashita K; Murata H; Beppu S; Koda T; Tada S; Shiraishi N; Sugiyama Y; Miyamoto K; Kusunoki S; Sugimoto T; Kumanogoh A; Okuno T; Mochizuki H
    J Neuroinflammation; 2021 Aug; 18(1):181. PubMed ID: 34419102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CSF-S100B Is a Potential Candidate Biomarker for Neuromyelitis Optica Spectrum Disorders.
    Wei Y; Chang H; Li X; Du L; Xu W; Cong H; Yao Y; Zhang X; Yin L
    Biomed Res Int; 2018; 2018():5381239. PubMed ID: 30426010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brain gadolinium enhancement along the ventricular and leptomeningeal regions in patients with aquaporin-4 antibodies in cerebral spinal fluid.
    Long Y; Chen M; Zhang B; Gao C; Zheng Y; Xie L; Gao Q; Yin J
    J Neuroimmunol; 2014 Apr; 269(1-2):62-7. PubMed ID: 24582827
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum neurofilament light chain and glial fibrillary acidic protein in AQP4-IgG-seropositive neuromyelitis optica spectrum disorders and multiple sclerosis: A cohort study.
    Liu C; Lu Y; Wang J; Chang Y; Wang Y; Chen C; Liu Z; Kermode AG; Zhang Y; Qiu W
    J Neurochem; 2021 Dec; 159(5):913-922. PubMed ID: 34278578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Markedly increased IP-10 production by blood-brain barrier in neuromyelitis optica.
    Shimizu F; Nishihara H; Sano Y; Takeshita Y; Takahashi S; Maeda T; Takahashi T; Abe M; Koga M; Kanda T
    PLoS One; 2015; 10(3):e0122000. PubMed ID: 25811465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulatory T cells protect against brain damage by alleviating inflammatory response in neuromyelitis optica spectrum disorder.
    Ma X; Qin C; Chen M; Yu HH; Chu YH; Chen TJ; Bosco DB; Wu LJ; Bu BT; Wang W; Tian DS
    J Neuroinflammation; 2021 Sep; 18(1):201. PubMed ID: 34526069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C5a-Preactivated Neutrophils Are Critical for Autoimmune-Induced Astrocyte Dysregulation in Neuromyelitis Optica Spectrum Disorder.
    Piatek P; Domowicz M; Lewkowicz N; Przygodzka P; Matysiak M; Dzitko K; Lewkowicz P
    Front Immunol; 2018; 9():1694. PubMed ID: 30083159
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD.
    Kleerekooper I; Herbert MK; Kuiperij HB; Sato DK; Fujihara K; Callegaro D; Marignier R; Saiz A; Senel M; Tumani H; De Jong BA; Trip SA; Nakashima I; Verbeek MM; Petzold A
    J Neurol Neurosurg Psychiatry; 2020 Jun; 91(6):605-611. PubMed ID: 32217788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
    Flanagan EP; Weinshenker BG; Krecke KN; Lennon VA; Lucchinetti CF; McKeon A; Wingerchuk DM; Shuster EA; Jiao Y; Horta ES; Pittock SJ
    JAMA Neurol; 2015 Jan; 72(1):81-7. PubMed ID: 25384099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lesions of the posterior limb of the internal capsule in neuromyelitis optica spectrum disorder.
    Long Y; Wu L; Zhong R; Ouyang X; Liang J; Gao C; Chen X; Qiu W; Chang Y; Wang Z; Ye J
    Neurol Res; 2017 May; 39(5):448-452. PubMed ID: 28262035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum Creatine Kinase in Patients with Neuromyelitis Optica Spectrum Disorder.
    Shouman K; Prieto PG; Stino AM; Lisak RP
    J Neuroimmunol; 2019 May; 330():87-89. PubMed ID: 30851543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S
    J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica.
    Tasaki A; Shimizu F; Sano Y; Fujisawa M; Takahashi T; Haruki H; Abe M; Koga M; Kanda T
    J Neurol Neurosurg Psychiatry; 2014 Apr; 85(4):419-30. PubMed ID: 24259591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The IL-10-producing regulatory B cells (B10 cells) and regulatory T cell subsets in neuromyelitis optica spectrum disorder.
    Cho EB; Cho HJ; Seok JM; Min JH; Kang ES; Kim BJ
    Neurol Sci; 2018 Mar; 39(3):543-549. PubMed ID: 29349658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Group 2 innate lymphoid cells suppress the pathology of neuromyelitis optica spectrum disorder.
    Kong Y; Li HD; Wang D; Gao X; Yang C; Li M; Chang T; Liu Q
    FASEB J; 2021 Nov; 35(11):e21856. PubMed ID: 34606651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.